GeneDx Holdings: KDJ Golden Cross and Bullish Marubozu on 15min chart

GeneDx Holdings's 15-minute chart has recently displayed a bullish signal, as it triggered a KDJ Golden Cross and a Bullish Marubozu at 08:25 on 08/25/2025. This indicates a shift in the momentum of the stock price towards the upside, suggesting that the stock has the potential to further increase in value. The dominance of buyers in the market, coupled with the prevailing bullish momentum, suggests that the trend is likely to continue.

In a recent trading update, Cathie Wood's ARK Invest ETFs demonstrated a strong tilt towards biotech stocks, allocating $46.2 million across several genomic and gene-editing names. The trades, disclosed on Monday, August 18, 2025, highlight ARK's bullish stance on the sector. Key investments included GeneDx Holdings, CRISPR Therapeutics AG, Beam Therapeutics, Intellia Therapeutics, and Pacific Biosciences of California [1].

ARKK ETF purchased 170,471 shares of GeneDx Holdings Corp (NASDAQ:WGS) for $21.5 million, reflecting a bullish stance on genomic research and personalized medicine. Additionally, the ETF bought 123,336 shares of Robinhood Markets Inc (NASDAQ:HOOD) for $14.1 million, indicating confidence in the fintech company's business model. The ETF also increased its position in CRISPR Therapeutics AG (NASDAQ:CRSP), acquiring 176,811 shares worth $10.6 million. This trade aligns with ARK's high conviction in gene-editing technologies. Moreover, the ETF purchased 395,097 shares of Beam Therapeutics Inc (NASDAQ:BEAM) valued at $7.0 million. The ETF also bought 10,273 shares of Deere & Co (NYSE:DE) for $5.0 million, reflecting ARK's interest in advanced technologies in agriculture [1].

ARKQ ETF sold 116,364 shares of Kratos Defense and Security Solutions Inc (NASDAQ:KTOS) for $7.9 million, suggesting a strategic shift away from defense stocks. The ETFs continued to add to positions in other biotech and tech companies, including Intellia Therapeutics Inc (NASDAQ:NTLA), Pacific Biosciences of California Inc (NASDAQ:PACB), and Figma Inc (PRIVATE:FIG), with total dollar values of $6.2 million, $886,703, and $3.7 million respectively. Smaller yet notable buys included 292,458 shares of Intuitive Machines Inc (NASDAQ:LUNR), 136,376 shares of PagerDuty Inc (NYSE:PD), 137,439 shares of Twist Bioscience Corp (NASDAQ:TWST), and 125,228 shares of 10X Genomics Inc (NASDAQ:TXG) [1].

These trades come on the heels of last week's pattern, where ARK consistently bolstered its biotech holdings, particularly in Beam Therapeutics, CRISPR Therapeutics, and Intellia Therapeutics, while also showing a sustained interest in Robinhood Markets. Investors following Cathie Wood's ARK ETFs should take note of these trades, as they may signal the fund's conviction in the growth potential of these companies and sectors [1].

References:
[1] https://www.investing.com/news/company-news/cathie-woods-ark-etf-bolsters-biotech-trims-defense-stock-93CH-4198906